Are two internal thoracic artery grafts as safe as one? Experience from Green Lane Hospital

Arul Baradi1, Paget F Milsom, Alan F Merry

  • 1Department of General Medicine, Auckland City Hospital, Auckland. New Zealand.

Insights

Bilateral internal thoracic artery (BITA) grafts showed no significant difference in short-term mortality or morbidity compared to single internal thoracic artery (SITA) grafts in coronary artery bypass grafting (CABG). These findings support considering BITA grafts for selected patients.

Area of Science:

  • Cardiovascular Surgery
  • Thoracic Surgery
  • Cardiac Surgery

Background:

  • Coronary artery bypass grafting (CABG) is a common procedure for treating coronary artery disease.
  • Internal thoracic artery (ITA) grafts are frequently used due to their long-term patency rates.
  • Bilateral internal thoracic artery (BITA) grafting versus single internal thoracic artery (SITA) grafting is debated regarding short-term outcomes.

Purpose of the Study:

  • To compare short-term mortality and major morbidity between BITA and SITA grafts in elective primary isolated CABG.
  • To evaluate the safety and efficacy of BITA grafting in a New Zealand cohort.

Main Methods:

  • Retrospective analysis of 5955 SITA and 637 BITA graft patients undergoing elective primary isolated CABG (1990-2004).
  • Primary outcome: composite endpoint of early death, perioperative myocardial infarction, reoperation for sternal wound complications, or prolonged hospital stay.
  • Case-matching was employed to control for confounding factors between BITA and SITA groups.

Main Results:

  • No statistically significant difference in the primary composite endpoint between BITA and SITA graft groups (OR 0.84; 95% CI 0.59-1.21).
  • No significant difference in reoperation rates for sternal wound complications between the two groups (OR 1.00; 95% CI 0.29-3.44).

Conclusions:

  • Short-term outcomes are comparable between BITA and SITA grafting in selected patients undergoing elective primary isolated CABG.
  • The study supports the consideration of BITA grafting due to potential long-term clinical benefits.
  • Further research may explore long-term survival and graft patency differences.
Abstract

Related Concept Videos